These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 27025324)

  • 21. [Treatment of tuberculosis].
    Dautzenberg B
    Rev Prat; 1996 Jun; 46(11):1350-5. PubMed ID: 8794618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. WHO recommendations on shorter treatment of multidrug-resistant tuberculosis.
    Sotgiu G; Tiberi S; D'Ambrosio L; Centis R; Zumla A; Migliori GB
    Lancet; 2016 Jun; 387(10037):2486-7. PubMed ID: 27353670
    [No Abstract]   [Full Text] [Related]  

  • 23. The most restrictive alternative.
    O'Connell J
    Med Health R I; 1996 Jan; 79(1):35-6. PubMed ID: 8705889
    [No Abstract]   [Full Text] [Related]  

  • 24. Antituberculosis drug resistance: practical solutions to practical problems.
    Tayler E
    J Med Microbiol; 1997 Jul; 46(7):531-3. PubMed ID: 9236735
    [No Abstract]   [Full Text] [Related]  

  • 25. Management of drug-resistant TB with individualised DST--the way forward?
    Singhal T; Gupta N
    J Assoc Physicians India; 2014 Jul; 62(7):561-3. PubMed ID: 25672025
    [No Abstract]   [Full Text] [Related]  

  • 26. A new epidemic.
    Mukherjee B
    J Indian Med Assoc; 1997 Apr; 95(4):119. PubMed ID: 9357279
    [No Abstract]   [Full Text] [Related]  

  • 27. Tuberculosis treatment: dangerous regimens?
    Rieder HL; Arnadottir T; Trébucq A; Enarson DA
    Int J Tuberc Lung Dis; 2001 Jan; 5(1):1-3. PubMed ID: 11263509
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug treatment options for multidrug-resistant tuberculosis.
    Patel K
    Conn Med; 1994 Apr; 58(4):227-30. PubMed ID: 8045123
    [No Abstract]   [Full Text] [Related]  

  • 29. Global spotlight falls on tuberculosis.
    Das P
    Lancet Infect Dis; 2004 Apr; 4(4):188. PubMed ID: 15072057
    [No Abstract]   [Full Text] [Related]  

  • 30. Programmatic versus personalised approaches to managing the global epidemic of multidrug-resistant tuberculosis.
    Chakaya JM; Marais B; du Cros P; Ntoumi F; Mfinanga S; Kapata N; Hasnain SE; Nathavitharana R; Zumla A
    Lancet Respir Med; 2020 Apr; 8(4):334-335. PubMed ID: 32113573
    [No Abstract]   [Full Text] [Related]  

  • 31. Multi-drug-resistant central nervous system tuberculosis.
    Murthy JM
    Neurol India; 2012; 60(2):143-5. PubMed ID: 22626692
    [No Abstract]   [Full Text] [Related]  

  • 32. M tuberculosis drug resistance in AIDS.
    Durrheim DN; Levin J; Weyer K
    Lancet; 1997 Jan; 349(9044):61; author reply 61-2. PubMed ID: 8988144
    [No Abstract]   [Full Text] [Related]  

  • 33. Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
    Yew WW; Chang KC; Chau CH
    J Antimicrob Chemother; 2009 Nov; 64(5):1119; author reply 1119-20. PubMed ID: 19666903
    [No Abstract]   [Full Text] [Related]  

  • 34. Investing in a novel shorter treatment regimen for multidrug-resistant tuberculosis: to be repeated.
    Yassin MA; Jaramillo E; Wandwalo E; Falzon D; Scardigli A; Kunii O; Weyer K
    Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28331045
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug development for tuberculosis: the missing ingredient.
    Reichman LB; Fanning A
    Lancet; 2001 Jan; 357(9251):236. PubMed ID: 11213133
    [No Abstract]   [Full Text] [Related]  

  • 36. AIDS and tuberculosis - a lethal combination.
    Ojcius D
    Nat Rev Microbiol; 2004 Nov; 2(11):858. PubMed ID: 15523763
    [No Abstract]   [Full Text] [Related]  

  • 37. The impact of drug resistance on the global tuberculosis epidemic.
    Schluger NW
    Int J Tuberc Lung Dis; 2000 Feb; 4(2 Suppl 1):S71-5. PubMed ID: 10688153
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapy of tuberculosis in the adult].
    Schrappe M; Wassermann K; Kroegel C
    Med Klin (Munich); 1995 Apr; 90(4):229-30. PubMed ID: 7776936
    [No Abstract]   [Full Text] [Related]  

  • 39. Multidrug resistant tuberculosis: trends and control.
    Prasad R; Gupta N; Singh M
    Indian J Chest Dis Allied Sci; 2014; 56(4):237-46. PubMed ID: 25962197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A threat to decentralised care for drug-resistant tuberculosis.
    Gray AT; Boyles T; Luedtke S; Sossen B; Birjovanu G; Kostkova P; Hughes J; Esmail H
    Lancet Respir Med; 2020 Oct; 8(10):950-952. PubMed ID: 33007284
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.